- Home
- FLUX vs ENLV Comparison
FLUX vs ENLV Comparison
Compare FLUX & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLUX
- ENLV
- Stock Information
- Founded
- FLUX N/A
- ENLV 2005
- Country
- FLUX United States
- ENLV Israel
- Employees
- FLUX N/A
- ENLV N/A
- Industry
- FLUX Industrial Machinery/Components
- ENLV Biotechnology: Pharmaceutical Preparations
- Sector
- FLUX Miscellaneous
- ENLV Health Care
- Exchange
- FLUX Nasdaq
- ENLV Nasdaq
- Market Cap
- FLUX 29.9M
- ENLV 24.4M
- IPO Year
- FLUX N/A
- ENLV 1995
- Fundamental
- Price
- FLUX $1.45
- ENLV $1.01
- Analyst Decision
- FLUX Strong Buy
- ENLV Strong Buy
- Analyst Count
- FLUX 4
- ENLV 2
- Target Price
- FLUX $9.00
- ENLV $9.50
- AVG Volume (30 Days)
- FLUX 69.0K
- ENLV 49.6K
- Earning Date
- FLUX 01-29-2025
- ENLV 03-28-2025
- Dividend Yield
- FLUX N/A
- ENLV N/A
- EPS Growth
- FLUX N/A
- ENLV N/A
- EPS
- FLUX N/A
- ENLV N/A
- Revenue
- FLUX $60,824,000.00
- ENLV N/A
- Revenue This Year
- FLUX N/A
- ENLV N/A
- Revenue Next Year
- FLUX $25.17
- ENLV N/A
- P/E Ratio
- FLUX N/A
- ENLV N/A
- Revenue Growth
- FLUX N/A
- ENLV N/A
- 52 Week Low
- FLUX $1.27
- ENLV $0.81
- 52 Week High
- FLUX $5.46
- ENLV $4.59
- Technical
- Relative Strength Index (RSI)
- FLUX 38.29
- ENLV 36.66
- Support Level
- FLUX $1.34
- ENLV $0.97
- Resistance Level
- FLUX $1.70
- ENLV $1.09
- Average True Range (ATR)
- FLUX 0.13
- ENLV 0.07
- MACD
- FLUX -0.02
- ENLV -0.00
- Stochastic Oscillator
- FLUX 30.64
- ENLV 23.53
About FLUX Flux Power Holdings Inc.
Flux Power Holdings Inc design, develop, manufacture, and sell a portfolio of lithium-ion energy storage solutions for electrification of a range of industrial commercial sectors which include material handling, airport ground support equipment (GSE), and other commercial and industrial applications It offers a high-power battery cell management system(BMS). The company's BMS provides three functions to its battery systems which include Cell Balancing, Monitoring, and Error Reporting.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.